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20-50-Oligoadenylate synthetases (OASs) produce
the second messenger 20-50-oligoadenylate, which
activates RNase L to induce an intrinsic antiviral
state. We report on the crystal structures of catalytic
intermediates of OAS1 including the OAS1$dsRNA
complex without substrates, with a donor substrate,
and with both donor and acceptor substrates. Com-
bined with kinetic studies of point mutants and the
previously published structure of the apo form of
OAS1, the new data suggest a sequential mechanism
of OAS activation and show the individual roles of
each component. They reveal a dsRNA-mediated
push-pull effect responsible for large conformational
changes in OAS1, the catalytic role of the active site
Mg2+, and the structural basis for the 20-specificity of
product formation. Our data reveal similarities and
differences in the activation mechanisms of mem-
bers of the OAS/cyclic GMP-AMP synthase family
of innate immune sensors. In particular, they show
how helix 3103-a5 blocks the synthesis of cyclic dinu-
cleotides by OAS1.
INTRODUCTION
Innate immunity forms one of the oldest antimicrobial defense
mechanisms in eukaryotes. It uses molecular pattern-recogni-
tion receptors (PRRs) to recognize microbial pathogen-associ-
ated molecular patterns (PAMPs) and thereby limits infections
by triggering immune responses (Kawai and Akira, 2011; Ronald
and Beutler, 2010). While PRRs recognize bacteria via a broad
range of PAMPs, viral PAMPs are more limited and commonly
consist of nucleic acids (Broz andMonack, 2013). During viral in-
fections, DNA and RNA species accumulate and are detected by
an array of different classes of PRRs, including RIG-I-like recep-
tors (RLRs), Toll-like receptors (TLRs), NOD-like receptors
(NLRs), and the cyclic GMP-AMP (cGAMP) synthase (cGAS)Structure 23and the 20-50-oligoadenylate synthetase (OAS) family of nucleo-
tidyltransferases (Hornung et al., 2014; Koyama et al., 2008).
Some nucleic acid PAMPs are common to both host and viruses.
The selectivity of the response to these viral patterns appears to
be mostly due to their localization in particular cellular compart-
ments, where the host molecules never occur. For example, a
crucial part of innate antiviral responses is the sensing of dsDNA
in the cytoplasm by cGAS (Li et al., 2013; Orzalli and Knipe,
2014). Long stretches of unmodified dsRNA, however, are pro-
duced by both RNA and DNA viruses but not by the host cell. Un-
modified dsRNA therefore plays a key role in triggering a cellular
antiviral state. As a result, the cell possesses several sensors of
dsRNA. PKR suppresses viral protein synthesis and contributes
to the establishment of the antiviral state. The RLR MDA5 forms
filaments on the dsRNA that allows the assembly of a scaffold of
signaling intermediates, thus inducing interferon production
(Reikine et al., 2014). Finally, OASs induce RNA cleavage by acti-
vating RNase L. The range of viral strategies to avoid dsRNA
detection is also an indication of the importance of this PAMP.
Ebola and Marburg viruses produce proteins to mask dsRNA,
as do influenza and poxviruses. Other viral strategies include
degradation of the dsRNA and inhibition of other steps in
dsRNA-triggered defense pathways (Hornung et al., 2014; Rei-
kine et al., 2014; Silverman, 2007).
OASs and cGAS generate linear or cyclic 20-50-linked
messenger molecules which, in turn, activate RNase L or Stimu-
lator of Interferon Genes (STING) immune signaling, respectively
(Hornung et al., 2014). The OAS/RNase L system was one of the
first interferon-induced antiviral pathways to be discovered. It
exhibits remarkable antiviral activity against herpes simplex virus
type 1 and RNase L-deficient cells becomemore permissive to a
spectrum of viruses responsible for human and animal diseases.
In addition, the OAS/RNase L pathway has been implicated in
antibacterial defense and the suppression of cancer (Chakrabarti
et al., 2011; Silverman, 2007). RNase L is activated by linear
20-50-linked oligoadenylates (2-5A) synthesized by OAS. The
OAS proteins OAS1/OASL, OAS2, and OAS3 are composed,
respectively, of one, two, and three repeats of homologous se-
quences referred to as OAS units. The catalytically active OAS
isoforms, such asOAS1, OAS2, andOAS3 inHomo sapiens, pro-
duce 2-5A in response to dsRNA (Kristiansen et al., 2011). The, 851–862, May 5, 2015 ª2015 Elsevier Ltd All rights reserved 851
inactive isoforms, such as OASL in Homo sapiens, exert their
antiviral function via different mechanisms (Kajaste-Rudnitski
et al., 2006; Lee et al., 2013; Zhu et al., 2014).
STING innate immune signaling is essential for the induction of
type I interferon by cytoplasmic DNA (Ishikawa et al., 2009). It is
activated by the cyclic dinucleotide (CDN) cGAMP(20-50) pro-
duced by cGAS and mediates interferon production in response
to viruses, mycobacteria, and intracellular parasites (Ablasser
et al., 2013; Bhat and Fitzgerald, 2014; Gao et al., 2013; Sun
et al., 2013; Wu et al., 2013). Both OAS enzymes and cGAS
belong to the nucleotidyltransferase superfamily and share
sequence homology, a common structural fold, and similar
active site architecture. These similarities led to the classification
of OAS enzymes and cGAS as one family of nucleic acid-sensing
nucleotidyltransferases (Hornung et al., 2014; Kranzusch et al.,
2013). The ability to sense pathogenic nucleic acids and
generate second messenger molecules following dsRNA/
dsDNA activation of enzymatic function distinguishes OAS/
cGAS from other nucleotidyltransferases.
OASs and cGAS have recently been subjects of structural
studies. Structural information now available for cGAS includes
structures of the apo enzyme, the dsDNA-bound states with
one andwith both substrates (ATP andGTP), intermediate states
of the cGAS reaction, and product-bound states. These data
form a solid basis for the elucidation of the activation and cata-
lytic mechanisms of cGAS. Structural data related to the mech-
anism of OASs are, however, less complete and consist only of
the structure of the apo state (Hartmann et al., 2003) and the
dsRNA complex with one substrate analog bound (Donovan
et al., 2013).
The structures of the OAS1 and cGAS proteins comprise an
N-terminal and a C-terminal lobe, and contain a central b-sheet.
The latter contains three conserved acidic active site residues
(D74/E200, D76/D202, and D147/D296 in porcine OAS1/
cGAS), which coordinate magnesium ions during catalysis (Civril
et al., 2013; Donovan et al., 2013; Gao et al., 2013). dsRNA/
dsDNA-induced activation of OAS/cGAS is accompanied by a
complex conformational change in the N-terminal lobe, which
primes the active site for catalytic competence.
OAS enzymes transfer an AMP unit from the AMP donor
substrate (ATP) to the 20-hydroxyl group of an AMP acceptor
substrate (ATP or a preformed 2-5A oligomer). This produces a
2-5A dimer (pppA(20-50)A) or an elongated 2-5A oligomer
(pppA((20-50)A)n), as well as one molecule of pyrophosphate
(PPi). In contrast to OASs, the cGAS reaction has a two-step nu-
cleotidyltransfer mechanism, which involves the initial formation
of a linear pppG(20-50)A intermediate from ATP (donor) and GTP
(acceptor), followed in a second step by a change in orientation
of the intermediate in the active site that permits the genera-
tion of cGAMP (Ablasser et al., 2013; Gao et al., 2013). The ques-
tion of why OAS can only form linear 2-5A, while cGAS forms
CDNs is still open (Hornung et al., 2014).
To address these and other open questions concerning the
functions of OAS/cGAS innate immune sensors, more details
of the OAS activation and catalysis mechanisms need to be
elucidated. For example, it is not clear whether the interaction
with viral dsRNA is sufficient for OAS1 to acquire its catalytically
active conformation and if not, what the individual roles of OAS1,
dsRNA, the AMP donor (ATP) and acceptor (ATP or 2-5A) sub-852 Structure 23, 851–862, May 5, 2015 ª2015 Elsevier Ltd All rightsstrates, and the Mg-cofactor are. It is also unknown whether
substrate binding occurs prior to the activation of OAS1 by
dsRNA or whether the latter is a prerequisite for the former.
Moreover, the origin of the 20-specificity of OAS1 remains an
open question.
Here, we report a series of structures of dsRNA-free OAS1 and
OAS1$dsRNA complexes without substrates and in complex
with one or two nonreactive ATP analogs. In combination with
mutagenesis studies, these structures allowed us to decipher
the detailed mechanism of OAS activation and the individual
role of each component in the process. The new structural
data together with molecular dynamics (MD) simulations re-
vealed the origin of the remarkable effect of viral dsRNA on
OAS conformation. The structures of the OAS1$dsRNA complex
with one and two ATP analogs in the active site (pre-reactive
state) demonstrated the structural basis for the 20-specificity of
OAS enzymes and revealed the functional role of Mg coordina-
tion in OAS activation and catalysis. A step-by-step comparative
analysis of the OAS and cGAS activation mechanisms explains
the structural basis by which these closely related enzymes syn-
thesize differing classes of products (linear 2-5As versus CDNs).
RESULTS
Inactive Form of OAS1
The inactive state of OAS1 is characterized by the absence of a
dsRNA ligand, an open conformation of the active site cleft, and
by the absence of detectable enzymatic activity (Hartmann et al.,
2003; Sarkar et al., 1999). Mixing the fluorescent ATP analog 20-/
30-O-(N0-methylanthraniloyl)-ATP (mantATP) with porcine OAS1
resulted in an increase of mantATP fluorescence indicating
that it binds to OAS1 in the inactive state. Fast mixing of OAS1
and mantATP revealed a second-order rate binding constant
kon = 8.3 ± 1.1 mM
1 s1 (Figures 1B–1D). Unmodified ATP dis-
placed mantATP from OAS1 yielding a rate of dissociation
koff = 104 ± 2 s
1. The ratio of the dissociation constant and sec-
ond-order rate binding constant, koff/kon, defines KD = 12.5 ±
1.9 mM for the OAS1$mantATP complex. The L149R point
mutant of OAS1 is unable to bind substrates in the AMP acceptor
site, as described below. Nevertheless, OAS1 L149R binds
mantATP with similar rate constants and affinity suggesting
that ATP binds to the AMP donor site in the inactive state
of OAS1.
We crystallized porcine OAS1 wild-type in the presence of
4 mM ATP. The structure of the putative OAS1$ATP complex
was solved to a resolution of 3.1 A˚. The overall conformation of
the obtained inactive OAS1 structure is very similar to the one
determined previously (Figure S1D). Although the kinetic exper-
iments indicate the binding of ATP to apo-OAS1, no ATP was
found in the active site of the apo structure. However, the new
structure of apo-OAS1 reveals the geometry of the loops con-
necting strands b1-b2 and b3-b4, which had not previously
been resolved in the apo state. Both of these regions form func-
tionally important parts of the active site: the former is involved in
the binding of dsRNA, the AMP donor substrate, and the cata-
lytic magnesium ions, while the latter coordinates the AMP
acceptor substrate (see below). In our apo-OAS1 structure
both the b1-b2 and the b3-b4 regions have b-hairpin conforma-
tions with a somewhat unstable network of hydrogen bondsreserved
Figure 1. Enzymatic Activity of OAS1 and
ATP Binding to the Inactive State
(A) Activation of OAS1 by poly(I:C) or the 19-bp
dsRNA used in crystallization. The number of in-
dependent experiments is five or three for poly(I:C)
or for the 19-bp dsRNA, respectively. The lower
axis indicates the concentration of both poly(I:C)
and the 19-bp dsRNA in mg/ml. The upper axis
indicates the molar concentration of the 19-bp
dsRNA only.
(B) Observed rate constants (kobs) upon fast mixing
of OAS1 wild-type or OAS1 L149R with mantATP.
The inset shows a representative averaged time
trace of the binding reaction.
(C) Dissociation of the OAS1$mantATP complex
by ATP. (B, C) Data were obtained from two in-
dependent experiments each averaging 5–8 indi-
vidual time traces. Schemes list concentrations of
reactants before/after mixing.
(D) Binding rate and dissociation constants for
mantATP binding by OAS1 wild-type and OAS1
L149R. Data are represented as means ± error of
the fit. Error bars represent the SD.
wt, wild-type.between the b-strands, especially in protein chain B. In the fully
activated form of OAS1 (see below), these regions undergo
large-scale conformational changes. Part of the b1-b2 hairpin
becomes an a-helical turn (a*), which is involved in the binding
of the AMP donor substrate. The restructuring of the b3-b4 re-
gion upon dsRNA binding brings residue R129 closer to the
active site, where it binds to the phosphate moiety of the AMP
acceptor.
RNA Binding and the RNA-Bound State
To study the structural effects of dsRNA-mediated activation, we
crystallized the binary complex of OAS1 bound to a 19-bp
dsRNA shown previously to be a strong activator of OAS1
(Kodym et al., 2009). OAS1 was activated by this dsRNA to a
maximal reaction velocity of 1.7 ± 0.1 s1 and an AC50 (concen-
tration required to elicit a 50% response in an in vitro assay) of
19.3 mg/ml (Kapp = 1.6 ± 0.1 mM), as measured by a steady state
PPi release assay (Figure 1). For comparison, poly(I:C) activated
OAS1 to a maximal velocity of 3.2 ± 0.1 s1 with an AC50 of
0.2 mg/ml.
The structure of the OAS1$dsRNA complex was solved to a
resolution of 2.25 A˚ (Figure 2A). dsRNA is bound to a positively
charged groove on the surface of OAS1 opposite the active
site. Amino acid residues of OAS1 contact the dsRNA at two
segments of the minor groove of the dsRNA helix. One of these
segments interacts predominantly with the N-terminal lobe of
OAS1 (residues 20–153) and the other predominantly with the
C-terminal lobe (residues 1–19 and 154–346). The N-terminal
and C-terminal lobes, respectively, contribute 53% and 47% of
the total buried solvent-accessible area of 3115 A˚2. This indi-Structure 23, 851–862, May 5, 2015cates that the two lobes contribute
approximately equally to dsRNA binding.
Most of the structural changes upon
dsRNA binding occur in the N-terminal
lobe of OAS1 (Figure 2B). dsRNA bindingleads to a widening of the N-terminal part of the RNA binding
groove. Helix a2 is shifted away from the dsRNA, which is
accompanied by a rotation of helix a3 (Figures 2C and 2D).
Strands b3, b4, b5, and b2 follow the movement of b1 and a3
leading to a reorientation of the central b-sheet. This includes a
shift in the hydrogen bond network between strands b3 and b4
(Figure 2E). At the same time, b1 is pulled upward to the RNA
binding site and an a-helical turn (a*) is generated in the loop be-
tween b1 and b2.
Since the displacement of strand b1 and of helix a2 toward and
away from the dsRNA, respectively, is a major effect observed in
the OAS1$dsRNA interface, we asked whether such a displace-
ment might be sufficient to induce the reorientation of the
central b-sheet seen upon dsRNA binding. The MD simulations
described in the Supplemental Experimental Procedures sup-
port this hypothesis and indicate that the displacements of a2
and b1 induce the rotation of helix a3 away from the dsRNA
and the reorientation of the central b-sheet toward the dsRNA
(Figure S1A–C). The part of the central b-sheet that is closest
to helix a3 follows its rotation, resulting in a change in the angle
of the b-strands.
Thus, the molecular forces generated by the dsRNA-induced
displacements of a2 and b1, which we refer to as the push-pull
effect, are propagated through the N-terminal lobe. The C-termi-
nal lobe serves as a stable foothold during this process, which
allows the opposing forces to restructure the N-terminal lobe.
Binding of the AMP Donor to dsRNA-Activated OAS1
To isolate the effects of each individual substrate on OAS1 acti-
vation, we constructed an OAS1 L149R mutant. This mutationª2015 Elsevier Ltd All rights reserved 853
Figure 2. Overview of the OAS1$dsRNA
Complex and Structural Changes upon
dsRNA Binding
(A) The OAS1$dsRNA complex.
(B) Superposition of OAS1 in the dsRNA-free state
(black) and the OAS1$dsRNA complex (blue).
(C and D) Superpositions of the N-terminal lobe (C)
and the central b-sheet (D) of dsRNA-free OAS1
(green) and the OAS1$dsRNA complex (blue).
(E) Hydrogen bond network in the central b-sheet.
See also Figure S1.was intended to block the AMP acceptor binding site, based on
the structure of the pre-reactive state of OAS1 (see below). No
catalytic activity could be detected for OAS1 L149R (Table 1).
We crystallized the ternary complex of OAS1 L149R, dsRNA,
and the substrate analog ApCpp and solved its structure to a res-
olution of 2.2 A˚ (Figure 3A). There is clear electron density for one
molecule of ApCpp and for two magnesium ions (Mg2+A and
Mg2+B) (Figure S3A). The closest distance between the ApCpp
ligand and the mutated residue R149 is 5.9 A˚. Therefore, the mu-
tation is not likely to affect the orientation of the ligand.
The binding of ApCpp shifts the central b-sheet of the N-termi-
nal lobe further toward the position of the dsRNA, comparedwith
its geometry in the OAS1$dsRNA complex (Figure 3B). This
movement extends the RNA-induced conformational change in
this area that had already been observed in the transition from
apo-OAS1 to the OAS1$dsRNA complex. In addition, loop
a*-b2 in the active site undergoes a major conformational
change upon substrate binding. The side chain of S73 moves
10 A˚ in order to contact the ApCpp g-phosphate. To test the sig-
nificance of this interaction, we constructed the OAS1 S73A
mutant. The catalytic activity of this mutant was reduced to
42%± 5%of the wild-type enzyme (Table 1), thus demonstrating854 Structure 23, 851–862, May 5, 2015 ª2015 Elsevier Ltd All rights reservedthat S73 is essential for the full activity
of the enzyme, as predicted from the
structure.
Other residues interacting with the
g-phosphate include the adjacent D74
(via a water molecule), S62 of the RNA-
induced a-helical turn, and the C-terminal
lobe residues K212 and Q229 (Figure 3C).
The b-phosphate forms a direct hydrogen
bond with S62 and water-mediated
hydrogen bonds with T67, K212, and
E233. The a-phosphate does not interact
directly with the protein. However, Mg2+A
and Mg2+B are coordinated by the three
catalytic aspartates D74, D76, and D147
and in turn coordinate the triphosphate
group of the substrate (Figure 3D).
Mg2+B has an octahedral coordination
sphere, formed by D74, D76, all three
phosphate groups of ApCpp, and an
additional water molecule. Mg2+A has a
distorted tetrahedral coordination sphere
formed by the a-phosphate, D74, D76,
and D147. The nucleoside ribose ringbinds to the deepest area of the active site pocket. The 20-hy-
droxyl group in particular forms hydrogen bonds with K65 and
Q193 and water-mediated contacts with T190 and the main
chain of G61 (Figure 3E). As a result, the ribose O20 becomes
strongly bound and solvent inaccessible, preventing its partici-
pation in the OAS-catalyzed reaction as an AMP acceptor.
Thus, the observed position of the substrate analog in the
OAS1L149R$dsRNA$ApCpp complex structure corresponds to
that of the AMP donor. This interpretation is supported by our
structure of the pre-reactive state of OAS1.
The unspecific hydrophobic interactions between the base of
the donor substrate and OAS1 (Figure 3C) explain the ability of
OAS1 to accept other nucleoside triphosphates (NTPs) and
dNTPs as donors in vitro (Hovanessian and Justesen, 2007). In
comparison with ApCpp, the dATPmolecule in the previously re-
ported OAS1$dsRNA$dATP complex shows a different orienta-
tion (Donovan et al., 2013). In this complex, the ribose moiety
of dATP is rotated by 180 compared with the ATP analog in
the OAS1L149R$dsRNA$ApCpp complex structure, pointing
outside the active site (Figure S3B). The interactions between
the 20-hydroxyl group of ApCpp andOAS1 suggest that the bind-
ing mode of dATP in the OAS1$dsRNA$dATP complex may be
Table 1. Enzymatic Activity of OAS1 Mutants
Construct Pyrophosphate release (%)
Wild-type 100
S73A 42 ± 5
R129A 62 ± 4
L149R n.d.
n.d., not detectable. See also Figure S2.affected by the lack of the 20-hydroxyl group. Thus, the pre-
sented structure of the OAS1L149R$dsRNA$ApCpp complex
may more accurately resemble the binding mode of the AMP
donor substrate in OAS enzymes.
In summary, binding of the AMP donor is accompanied by two
magnesium ions and induces a shift of the central b-sheet
toward the dsRNA and amajor restructuring of loop a*-b2. Coor-
dination bonds with the two magnesium ions are mostly respon-
sible for triphosphate binding. The ribose interacts with the
active site through hydrogen bonds, especially with its 20-hy-
droxyl group, while the base contacts the protein via unspecific
hydrophobic interactions.
Binding of the AMP Acceptor and Formation of the
Pre-reactive State
In an attempt to resolve the geometry of the OAS1 kinetic state
immediately prior to its catalytic reaction, we crystallized wild-
type OAS1 in the presence of dsRNA and ApCpp. The structure
was solved to a resolution of 2.0 A˚. Two ApCpp substrate mole-
cules (AMP donor and AMP acceptor) were observed in the
active site, together with the two magnesium ions Mg2+A and
Mg2+B (Figures 4A and S4F). The overall structure of the
OAS1wt$dsRNA$ApCpp2 complex is very close to that of the
OAS1L149R$dsRNA$ApCpp complex containing only the AMP
donor substrate analog (Figure 4B). Differences are observed
in the flexible loop b3-b4 and the adjacent part of the
strand b3, which are shifted toward the active site in the
OAS1wt$dsRNA$ApCpp2 complex. The binding mode of
the AMP donor substrate as well as the position of Mg2+B and
the conformation of the active site residues involved in its binding
remain the same as in the OAS1L149R$dsRNA$ApCpp structure.
The AMP acceptor substrate binds with its base positioned at
an angle of 90 relative to the base of the AMP donor and the
phosphate moieties of both substrates are directed away from
each other (Figure 4C). In this binding mode, the 20-oxygen
atom of the second ApCpp molecule is in close proximity to
the a-phosphate of the AMP donor (distance of O20–Pa, 3.0 A˚).
The O20 atom of the AMP acceptor substrate and the Pa-O3A
of the AMP donor lie on an almost straight line (angle of 174).
This arrangement is favorable for a nucleophilic attack by O20
on Pa. This reaction would generate the 5
0-triphosphorylated,
20-50-linked 2-5A dimer and a pyrophosphate. Thus, the struc-
ture of the OAS1wt$dsRNA$ApCpp2 complex corresponds to
the pre-reactive state of OAS1 and reveals the basis for the
20-specific formation of the 2-5A products. The presence of the
second ApCpp substrate molecule reveals the geometry and
the binding mode of the AMP acceptor substrate.
The binding of the AMP acceptor substrate complements the
coordination sphere of the Mg2+A ion with the O2
0 hydroxyl of theStructure 23acceptor ribose and an additional water molecule, which results
in a higher octahedral symmetry (Figure 4C). The carboxyl
oxygen of D147 moves closer to the metal ion, forming a
classical coordination bond interaction. These effects stabilize
the pre-reactive geometry, which is reflected in the higher
levels of electron density in this area compared with the
OAS1L149R$dsRNA$ApCpp complex structure.
Thus, both Mg2+ ions play an important role in proximity and
orientation effects of OAS catalysis together with the amino
acid residues of the active site.
The adenosine base of the AMP acceptor substrate binds in
the active site pocket next to the ribose ring of the AMP donor
(Figures 4C and 4D). The base is coordinated both by hydrogen
bonds with S186, T190, and Q193 and hydrophobic interactions
with V78, L149, and T187. The only interaction of the triphos-
phate group of the AMP acceptor with OAS1 is a hydrogen
bond between the a-phosphate and R129. The b- and g-phos-
phates of the AMP acceptor are directed outward of the active
site cleft and are fully solvent accessible. R129, located close
to the beginning of strand b4, changes its conformation upon
binding of the AMP acceptor, which induces a shift of strands
b3 and b4 toward the active site. To determine the importance
of R129 for substrate binding, we mutated R129 to alanine.
This led to a reduction in OAS1 activity to 62% ± 4% of the
wild-type (Table 1).
In summary, binding of the AMP acceptor substrate induces
local conformational changes in the area of b3-b4 and the cata-
lytic center, rendering the active sitemore compact and ordered.
The twomagnesium ions play essential roles in substrate binding
and the acquisition of a pre-reactive state geometry. The
observed structural changes induced by the binding of the
AMP donor substrate, especially the geometry of the magne-
sium-containing catalytic center, facilitate binding of the AMP
acceptor substrate. With the binding of both substrates, OAS1
acquires a fully active conformation optimal for nucleophilic
attack of theO20 of theAMPacceptor on thePaof theAMPdonor,
which establishes the basis for the 20-specific formation of 2-5A.
DISCUSSION
Our binding studies suggest that OAS1 in its dsRNA-free inactive
state can bind ATP at the AMP donor substrate site, although
ATP could not be localized in our crystal structure of apo-
OAS1. NTP binding to the donor substrate site of DNA-free
cGASwas also observed (Civril et al., 2013). However, to synthe-
size the 2-5Amessenger molecules and to trigger innate antiviral
immune responses, OAS1 has to bind dsRNA. RNA binding
causes displacements of helix a2 and strand b1 in the OAS-
RNA interface. Our MD simulations reveal the allosteric
mechanism that supports the propagation of the a2 and b1 dis-
placements into a major restructuring of the whole N-terminal
lobe (push-pull effect). The binding of dsRNA causes the forma-
tion of the helical turn a*, which constitutes a major part of the
binding site for the AMP donor in the active state of OAS1.
Binding of the AMP donor substrate and the two Mg2+ ions is
accompanied by an additional shift of the central b-sheet in the
N-terminal lobe and a large-scale conformational change of
loop a*-b2. At the amino acid level, loop a*-b2 is similar to
the nucleotide-binding (NB) loop of the nucleotidyltransferase, 851–862, May 5, 2015 ª2015 Elsevier Ltd All rights reserved 855
Figure 3. Overview and Substrate Binding
of the OAS1L149R$dsRNA$ApCpp Complex
(A) Overview of the OAS1L149R$dsRNA$ApCpp
complex.
(B) Superposition of the OAS1$dsRNA (blue) and
the OAS1L149R$dsRNA$ApCpp (orange) complex
central b-sheets.
(C) Binding mode of the AMP donor substrate. The
adenine base binds to a part of the active site that
is formed by conserved residues of the C-terminal
lobe. These residues do not change their position
during the transition from the dsRNA-free to the
OAS1$dsRNA complex or by binding of ApCpp.
Y230 and V308 form a flat hydrophobic surface,
which stacks against the base. Residues D300,
G306, N307, and the main chain of V308 form a
ridge around this surface, which is complementary
in shape to the Watson-Crick edge of adenosine.
Q193 makes a hydrogen bond with the N(3) atom
of the adenine base. Another hydrogen bond is
formed between the amide nitrogen of Y230 and
the N(7) atom.
(D) Magnesium coordination in the OAS1L149R$
dsRNA$ApCpp complex.
(E) Hydrogen bonds between OAS1 and the ribose
moiety of the AMP donor. See also Figure S3.superfamily (Peneff et al., 2001; Steiner et al., 2007). As a close
structural analog of the NB loop identified in the cytosolic DNA
sensor cGAS (Civril et al., 2013), loop a*-b2 of OAS1 is referred
to as the NB loop. The NB loop in OAS1 plays a prominent role
in the activation mechanism. The interaction of the AMP donor
g-phosphate with S73 of OAS1 brings the adjacent D74 to the
optimal position for binding Mg2+ ions and the AMP acceptor.
The accompanying shift of the central b-sheet further increases
the complementarity of the active site geometry to the AMP
acceptor, thus facilitating its binding. The significance of the
NB loop for OAS1 activation is also supported by the decreased
activity seen for the OAS1 S73A mutant.
The binding of the AMP donor together with the two Mg2+ ions
creates a complementary binding site for the AMP acceptor. The
need for an AMP donor in the active site to bind the AMP856 Structure 23, 851–862, May 5, 2015 ª2015 Elsevier Ltd All rights reservedacceptor is also supported by the results
reported by Donovan et al. (2013). Only
one dATP is present in the active site of
their OAS1$dsRNA$dATP complex struc-
ture, occupying the donor site.
Our structure of the OAS1$dsRNA$
ApCpp2 complex presents the first in-
sights into the binding mode of the AMP
acceptor and the geometry of the pre-
reactive state. The presence of the two
magnesium ions in the active site is
consistent with the two metal ion mecha-
nism that has been proposed for enzymes
and ribozymes acting on nucleic acid syn-
thesis or degradation (Steitz and Steitz,
1993; Yang et al., 2006). In this mecha-
nism, both ions serve to position the sub-
strates. Furthermore, Mg2+A increasesthe reactivity of the nucleophilic attack of the 20-oxygen of the
acceptor substrate on the a-phosphate of the donor substrate.
Mg2+B stabilizes both the pentacovalent intermediate state dur-
ing the nucleophilic attack and the leaving group (PPi).
The structure of the OAS1wt$dsRNA$ApCpp2 complex reveals
the basis of the 20-specific formation of the antiviral second
messenger 2-5A. A comparison with the 30-specific nucleotidyl-
transferases poly(A) polymerase (PAP) and CCA-adding enzyme
(CCA) indicates that the orientation of the donor substrate is
conserved and that the 20-specificity of OAS enzymes is
achieved by the binding mode of the acceptor substrate (Figures
4E and 4F) (Balbo and Bohm, 2007; Pan et al., 2010). The inter-
action between the a-phosphate of the AMP acceptor substrate
and R129 of loop b3-b4 is unique to OAS1. In PAP and CCA, the
50-end of the acceptor is positioned more centrally above the
Figure 4. Overview and Substrate Binding
of the Pre-reactive OAS1wt$dsRNA$ApCpp2
Complex
(A) Overview of the OAS1wt$dsRNA$ApCpp2
complex.
(B) Superposition of the OAS1L149R$dsRNA$
ApCpp (orange) and the OAS1wt$dsRNA$ApCpp2
(beige) complex.
(C) Substrate orientation in the OAS1wt$dsRNA$
ApCpp2 complex.
(D) Binding mode of the AMP acceptor substrate.
(E and F) Superposition of the central b-sheets and
acceptor substrates (E) or donor substrates (F)
of the OAS1wt$dsRNA$ApCpp2 complex (beige),
PAP (PDB code: 2Q66, blue) and CCA (PDB code:
3OVA, green). See also Figure S4.b-sheet. Y87 of PAP and F63 of CCA, corresponding to G60 and
V78 in OAS1, respectively, form areas of the active site that are
occupied by the base of the acceptor substrate in OAS1 (Fig-
ure S4). Therefore, the absence of bulky amino acid side chains
in these positions allows a downward rotation of the acceptor
nucleoside toward the central b-sheet in OAS1. This is further
supported by the orientation of helix a5 in OAS1. The rotation
of the acceptor nucleoside and a-phosphate places the 20-hy-
droxyl at the reactive center for the 20-specific OAS1 and the
30-hydroxyl at the reactive center for the 30-specific PAP and
CCA. In the case of cGAS, a single point mutation was sufficient
to reprogram the enzyme to produce 30-50-linked cGAMP (Kran-
zusch et al., 2014). Although there is no structural homolog of theStructure 23, 851–862, May 5, 2015mutated residue in OAS1, we investi-
gated whether OAS1 could be similarly
reprogrammed by point mutations to pro-
duce 30-50 linked oligoadenylate. Our
in silico studies predict that replacing
G60 of OAS1 by a bulky tyrosine
(mimicking the active site of CCA) could
lead to a higher rotation angle of the
acceptor nucleoside, bringing the 30-hy-
droxyl to the reactive position. This
prediction suggests a possible means
of reprogramming OAS1 to produce
30-50-linked products, similarly to cGAS,
which requires further experimental
investigation.
The 2-5A products of OAS1, OAS2, and
OAS3 have different length ranges, with
OAS1 synthesizing mostly 2-5A dimers
and trimers, OAS2 the longest oligomers,
and OAS3 intermediate 2-5A oligomers
longer than a trimer (Ibsen et al., 2014;
Morin et al., 2010; Rebouillat et al.,
1999). Based on the structure of the pre-
reactive state of OAS1, we produced ho-
mology models of the catalytically active
C-terminal OAS unit for human OAS2
and OAS3. We modeled the 2-5A dimer
in the AMP acceptor position in OAS1,
2, and 3. In all models, the active sitepocket accommodates the 2-5A dimer without steric clashes
and allows enough space for higher 2-5A oligomers. The pre-
dicted product release channel, however, is tighter in OAS2
than OAS1 and has an intermediate shape in OAS3 (Fig-
ure S4G–S4I). Correspondingly, the predicted binding affinity
for the 2-5A dimer is highest in OAS2, lower in OAS3, and lowest
in OAS1. Thus, stabilization of 2-5A oligomers in the acceptor
position by residues in the product release channel may deter-
mine the product length of the different OAS enzymes.
To obtain new insights in the structure-function relationship of
the OAS/cGAS family of innate immune sensors, we compared
structures of both enzymes for each kinetic state. The inactive
apo forms of OAS1 and cGAS (Civril et al., 2013; Gao et al.,ª2015 Elsevier Ltd All rights reserved 857
(legend on next page)
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2013) have similar folds but show conformational differences in
their N-terminal lobes. When compared with the respective
active states of the enzymes (Figures 5A and 5B), the apo form
of cGAS is much closer to its active state than is the case for
OAS1. The conformational transition between the inactive and
active forms of cGAS does not require the major rotation of the
central b-sheet seen for OAS1.
Upon dsRNA or dsDNA binding, both enzymes undergo
similar conformational changes but with a smaller magnitude in
the case of cGAS (Figures 5C and 5D). The similarities in the
conformational transitions from the apo- to the nucleic acid-
bound forms of OAS1 and cGAS raise the question of whether
the activation of cGAS also involves the push-pull allosteric
mechanism seen for OAS1. To test this hypothesis, we per-
formed the sameMD simulations as for OAS1 (see Supplemental
Experimental Procedures), where opposing force vectors were
applied to the DNA interface elements helix a2 and strand b1
of a separated cGAS monomer in the apo state. The position
of the C-terminal lobe was restrained. After only 20 ps of dy-
namic trajectory, the cGASmonomer acquired a geometry close
to that of the active state. The shorter dynamic trajectory is in
agreement with the smaller magnitude of conformational change
needed for cGAS activation. Thus, the MD simulations indicate
that the push-pull mechanism of activation is also present in
cGAS.
The binding of the AMP donor substrate to nucleic acid-acti-
vated OAS1 and cGAS results in very similar binding modes of
the substrate and the catalytic Mg2+ ions (Figures 5E and 5F).
In contrast to OAS1, the NB loop and the central b-sheet of
cGAS do not undergo further conformational changes upon
binding of the donor substrate.
Similar to what is seen in OAS1, the binding of the second sub-
strate does not cause noticeable changes to the structure of
cGAS. The geometries of OAS1 and cGAS in complex with their
nucleic acids and both substrates show striking similarities (Fig-
ure 5G), which supports the evolutionary connection between
these enzymes. The binding mode and the orientation of the
donor and acceptor substrates in both enzymes are similar
with the main difference observed in the positioning of the nucle-
oside moieties of the acceptor substrates. This difference may
be caused by the lack of the second Mg2+ ion (Mg2+A) in the
cGAS$DNA$GTP$ATP complex structure (Civril et al., 2013).
Since both Mg2+ ions were resolved in the pre-reactive state
structure of OAS1, we superimposed the structures of
OAS1$dsRNA$ApCpp2 and cGAS$DNA$GTP$ATP complexes
to analyze the possible bindingmode of Mg2+A and the pre-reac-
tive state geometry in cGAS, assuming that the catalytic mech-
anism is similar in both enzymes. The superposition suggestsFigure 5. Comparison of OAS and cGAS Activation Mechanisms by ds
(A and B) Superpositions of OAS1 structures (this work) in the apo and pre-reacti
codes: 4JLZ and 4KB6, respectively).
(C and D) Push-pull effect in OAS1 and cGAS. The superposition in (D) shows
code: 4K96).
(E) Superposition of the OAS1$dsRNA complex and the OAS1L149R$dsRNA$ApC
(F) Superposition of the cGAS$DNA complex (PDB code: 4K96) and the cGAS$D
(G) Superposition of the pre-reactive states of OAS1 and cGAS (PDB code: 4KB
(H) Superposition of the OAS1 pre-reactive state and cGAS in complex with DNA
OAS1 do not allow a binding mode of linear dinucleotides that could give rise to
Structure 23that Mg2+A in the cGAS pre-reactive state binds between the
O20-group of GTP and the a-phosphate group of ATP and in-
cludes conserved residues E200, D202, and D296 in the magne-
sium coordination sphere. Mg2+A binding brings the reagents
into closer proximity and facilitates the acquisition of the trigonal
bipyramidal geometry that is observed in the OAS1 pre-reactive
state and is characteristic for SN2 reaction mechanisms in nucle-
otidyltransferases. It has been shown that Mg2+ binding in other
nucelotidyltransferases has a flattening effect on the a-phos-
phate geometry of the electrophile, rendering it closer to the
transition state and contributing to an elongation of the Pa-O
covalent bond, which facilitates dissociation along this bond
(Fu¨hring et al., 2013). Comparison of the donor substrates in
the OAS1$dsRNA$ApCpp2 and cGAS$DNA$GTP$ATP com-
plexes reveals that the same activation effects on the a-phos-
phate geometry are observed in OAS1 while they are absent in
the structure of the cGAS$DNA$GTP$ATP complex lacking
Mg2+A. Thus, Mg
2+
A contributes to the proximity and orientation
effect and provides bond strain and electrostatic activation dur-
ing catalysis in cGAS and OAS enzymes.
Comparison of the OAS1 pre-reactive state structure with the
structure of cGAS in complex with DNA and the pG(20,50)A
intermediate (Gao et al., 2013) provides insights into the open
question of why cGAS forms CDNs, whereas OAS1 forms linear
oligomeric chains (Hornung et al., 2014). The position of helices
3103-a5 in OAS1 do not allow the binding of CDN intermediates
while in cGAS such a binding is possible (Figure 5H). Interest-
ingly, the same 3103-a5 region in OAS1 is also an important
determinant of the 20-specificity of OAS product formation.
To summarize, nucleic acid-induced activation in the OAS1/
cGAS family follows a conserved mechanism, which involves
the push-pull effect of dsRNA/dsDNA on the interface elements
a2 and b1 and the propagation of this effect through the N-ter-
minal lobe. This leads to the rotation and shift of the central
b-sheet and the formation of the active site geometry. The a*
element and the NB loop are essential elements in binding the
donor substrate and Mg2+ ions, and in preparing the binding
site for the acceptor substrate. Activation of cGAS requires
considerably smaller conformational changes than does
OAS1. The divergence of OAS1 and cGAS function in terms of
the synthesis of linear 2-5As versus CDNs is achieved in
OAS1 via steric blocking of CDN intermediates by helices
3103-a5, preventing the formation of CDNs as performed by
cGAS. The 20-specificity of the product formation in the OAS/
cGAS family is determined by the orientation of the acceptor
substrate in the active site.
The new data presented here and the detailed analysis of the
activation mechanisms of the OAS1/cGAS family provides newRNA and DNA PAMPs
ve states (A) and cGAS structures in the apo- and DNA-bound states (B) (PDB
the apo form of cGAS (PDB code: 4K8V) and the cGAS$DNA complex (PDB
pp complex with ApCpp in the donor site.
NA$ATP complex (PDB code: 4K97).
6).
and the linear dinucleotide intermediate (PDB code: 4K9A). Helices 3103-a5 of
CDNs.
, 851–862, May 5, 2015 ª2015 Elsevier Ltd All rights reserved 859
Table 2. Crystallographic Data and Refinement Statistics for the Structures of OAS1 in Various States
OAS1-apo (PDB code:
4RWQ)
OAS1$dsRNA (PDB code:
4RWP)
OAS1L149R$dsRNA$ApCpp
(PDB code: 4RWO)
OAS1wt$dsRNA$ApCpp2
(PBD code: 4RWN)
Data Collection
Beamline ID23-1, ESRF ID23-2, ESRF ID23-1, ESRF 14.1, BESSY
Wavelength (A˚) 0.87260 0.87260 1.06450 0.91841
Space group C2 P43212 P43212 P43212
Unit cell parameters (A˚; ) 79.84, 145.08, 80.14
90.0, 106.4, 90.0
72.67, 72.67, 189.53
90, 90, 90
73.1, 73.1, 208.4
90, 90, 90
72.4, 72.4, 205.95
90, 90, 90
Resolution range (A˚)a 45.5–3.1 (3.2–3.1) 47.7–2.25
(2.53–2.25)
46.3–2.2 (2.3–2.2) 41.0–2.0 (2.1–2.0)
Crystal mosaicity () 0.226b 0.175b 0.3 0.217
Wilson B-factor 72.4 49.3 57.9 39.9
Unique reflections 15,919 (1456) 25,074 (3007) 29,636 (3601) 37,965 (5050)
Multiplicity 12.2 (12.4) 14.0 (14.3) 11.0 (7.7) 6.5 (6.3)
<I/s(I)> 12.04 (2.66) 16.1 (2.4) 13.8 (2.9) 16.0 (4.3)
Completeness (%) 100 (100) 100 (100) 99.6 (99.7) 99.5 (97.1)
Rsigma (%)
c 6.1 (37.9) 4.8 (43.4) 4.4 (33.0) 3.9 (23.5)
Rint (%)
c 16.8 (66.5) 14.4 (73.8) 9.3 (52.5) 6.6 (41.3)
Structure Refinement
Rwork (%) 21.0 19.4 20.2 18.8
Rfree (%) 26.0 22.6 23.7 23.4
No. non-hydrogen atoms 5617 3671 3725 3961
No. waters 1 98 73 253
No. protein residues/RNA bases 692/0 346/36 347/38 349/38
Protein/dsRNAmolecules per a.u. 2/0 1/1 1/1 1/1
Geometry
Coordinate error (A˚) 0.44 0.22 0.27 0.23
Rmsd, bond lengths (A˚) 0.003 0.006 0.017 0.003
Rmsd, bond angles () 0.660 0.813 1.050 0.808
Baverage (A˚
2) 97.2 41.0 54.6 37.9
No. of TLS groups 9 – – –
Statistics for the highest-resolution shell are shown in parentheses. Rmsd, root mean square deviation; TLS, translation/libration/screw.
aHigh-resolution cutoffs were applied to resolution shells that had the average error in the intensities Rsigma >50% or had sustained high radiation
damage.
bAverage across data batches.
cRsigma = S[s(Fo
2)]/S[Fo
2]; Rint = SjFo2  Fo2(mean)j/S[Fo2].fundamental insights into the function of these key innate im-
mune sensors.EXPERIMENTAL PROCEDURES
Protein Preparation
A plasmid coding for wild-type porcine OAS1 with a C-terminal His6-tag was a
kind gift from Rune Hartmann, Aarhus University, Denmark. Mutants were
generated by site-directed mutagenesis.
OAS1 wild-type and mutants were expressed in Escherichia coli Rosetta
(DE3) pLysS cells and purified following Torralba et al. (2008). Deviating
from the original protocol, the following buffers were used. Lysis buffer:
25 mM HEPES (pH 8.0), 300 mM NaCl, 20 mM imidazole, 5 mM b-mercap-
toethanol, 1 mM EDTA, 0.1 mM PMSF, 0.1% IGEPAL, 10% glycerol).
Wash buffer A: 25 mM HEPES (pH 8.0), 500 mM NaCl, 20 mM imidazole,
10% glycerol. Wash buffer B: 25 mM MES (pH 6.0), 500 mM NaCl, 20 mM
imidazole, 10% glycerol. Wash buffer C: 25 mM HEPES (pH 6.8), 500 mM
NaCl, 20 mM imidazole, 10% glycerol. Elution buffer: wash buffer C supple-
mented with 200 mM imidazole. The protein was dialyzed into 10 mM860 Structure 23, 851–862, May 5, 2015 ª2015 Elsevier Ltd All rightsHEPES (pH 7.2), 330 mM NaCl, 10 mM MgCl2, 2 mM DTT, 3% glycerol,
and stored at 80C.
Crystallization
OAS1 crystals were grown bymixing 0.25 ml of OAS1 at 6mg/ml supplemented
with 4 mM ATP with 0.25 ml of reservoir solution (0.2 M (NH4)2SO4, 0.1 M
sodium acetate [pH 5.5], 10% PEG 2000 MME) in a 96-well sitting drop vapor
diffusion plate. Crystals were transferred into reservoir supplemented with
15% ethylene glycol before flash-freezing in liquid nitrogen.
OAS1$dsRNA complexes were set up by mixing OAS1 wild-type or OAS1
L149R with dsRNA in 10 mM HEPES (pH 7.2), 330 mM NaCl, 10 mM MgCl2,
2 mM DTT, 3% glycerol. One strand of the dsRNA fragment (Oligo Factory)
had the sequence GGCUUUUGACCUUUAUGAA annealed to its reverse
complementary strand. For the OAS1$dsRNA complex, concentrations were
6 mg/ml OAS1 and 2.7 mg/ml dsRNA. The complexes of OAS1L149R$dsRNA$
ApCpp and OAS1wt$dsRNA$ApCpp2 were set up with 5.7 mg/ml OAS1 and
2.5 mg/ml dsRNA in the presence of 0.5 mM ApCpp (Jena Bioscience). Crys-
tals of the OAS1$dsRNA and OAS1L149R$RNA$ApCpp complex were grown in
96-well HTS sitting drop plates by mixing 0.25 ml of the complex solution 1:1
with reservoir solution. Crystals of the OAS1wt$dsRNA$ApCpp2 complexreserved
were grown by mixing 1.5 ml of the complex solution 1:1 with reservoir in a
hanging drop vapor diffusion setup. Reservoir solutions were 100 mM KCl,
100mMHEPES (pH 7.0), 15%PEG 5000MME for the OAS1$dsRNA complex,
100 mM Tris-HCl (pH 8.0), 25% PEG 400 for the OAS1L149R$dsRNA$ApCpp
complex or 50 mM Tris-HCl (pH 8.3), 100 mM KCl, 10 mM MgCl2, 23% PEG
400 for the OAS1wt$dsRNA$ApCpp2 complex. Crystals were transferred into
reservoir solution supplemented with 10% ethylene glycol (OAS1$dsRNA
complex), 15% ethylene glycol (the OAS1L149R$dsRNA$ApCpp complex), or
100 mM Tris-HCl (pH 8.0), 50% PEG 200 (OAS1wt$dsRNA$ApCpp2).
Data Collection and Structure Solution
Data were collected at beamlines MX 14.1, BESSY, Berlin, BM30A, ID23-1
and -2, ESRF, Grenoble and processed with XDS (Kabsch, 2010). Molecular
replacement was performed with AMoRe (Navaza, 1994) of the CCP4 suite
(Winn et al., 2011) or Phaser (McCoy et al., 2007) via the Phenix suite (Adams
et al., 2010). The previously published model of apo-OAS1 (PDB code: 1PX5)
was used as a search model for our apo-OAS1 structure crystallized in the
presence of ATP and for the pre-reactive state structure. The protein part of
the pre-reactive state model was used as a search model for the other
OAS1$dsRNA complexes. Simulated annealing in cns (Brunger, 2007) and
phase improvement in Arp/Warp (Langer et al., 2008) yielded the electron den-
sity for dsRNA, which was built manually in coot (Emsley et al., 2010). Further
rounds of refinement were performed with phenix.refine (Adams et al., 2010) or
Refmac5 (Murshudov et al., 2011;Winn et al., 2011) and Coot. The final models
had good stereochemistry and low coordinate errors (Table 2).
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Coordinates for the structures apo-OAS1, OAS1$dsRNA, OAS1L149R$dsRNA$
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